DOCTOR DANDRUF 2N1 SHAMP CLN APL 13.5FLOZ SKU 2005726 SUAVE 2N1 MENS CC ANTI DNDRF SHMP 28 FLOZ...

FDA Drug Recall #D-1379-2022 — Class II — June 23, 2022

Recall Summary

Recall Number D-1379-2022
Classification Class II — Moderate risk
Date Initiated June 23, 2022
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Family Dollar Stores, Llc.
Location Chesapeake, VA
Product Type Drugs
Quantity Unknown

Product Description

DOCTOR DANDRUF 2N1 SHAMP CLN APL 13.5FLOZ SKU 2005726 SUAVE 2N1 MENS CC ANTI DNDRF SHMP 28 FLOZSKU 2006512 MANE N TAIL 2 IN 1 ANTI DANDRUFF 12 FL OZ SKU 2024652 HEAD AND SOULDERS 2N1 SMOOTH SILKY 12.8 FL OZ SKU 2097272 DOCTOR MED DANDRUFF TREAT 11 FL OZ SKU 2005531 HEAD AND SOULDERS CLASSIC CLEAN SH 13.5 OZ SKU 2099110 DOCTOR DANDRUF 2IN1 SHAM DRYSCLP 13.5FL OZ SKU 2038805 HEAD AND SOULDERS 2IN 1 DRY SCALP 13.5 FL OZ SKU 2038366 HEAD AND SOULDERS 2IN 1 DRY SCALP SHAMPOO 23.7 FLOZ SKU 2005504 DOCTOR DANDRUFF 2N1 SHAMPOO 13.5FL OZ SKU 2038806 DOCTOR SHAMPOO T GEL 8.5 FL OZ SKU 2038935 DOCTOR 2N1 DANDRUFF CLSC 23.7FLOZ SKU 2005121 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.

Reason for Recall

CGMP Deviations: product held outside appropriate storage temperature conditions.

Distribution Pattern

Nationwide within the United States

Lot / Code Information

SKUs: 2005726; 2006512; 2024652; 2097272; 2005531; 2099110; 2038805; 2038366; 2005504; 2038806; 2038935; 2005121

Other Recalls from Family Dollar Stores, Llc.

Recall # Classification Product Date
D-0566-2023 Class II Advil Liqui-Gels Solubilized Ibuprofen Capsules... Mar 31, 2023
D-0563-2023 Class II Advil Ibuprofen Tablets, 200 mg Pain Reliever/F... Mar 31, 2023
D-0565-2023 Class II Advil Dual Action with Acetaminophen Acetaminop... Mar 31, 2023
D-0564-2023 Class II Advil Ibuprofen Tablets, 200 mg Pain Reliever/F... Mar 31, 2023
D-1470-2022 Class II Colgate Whitening Mouthwash, OPTIC WHITE ICY FR... Aug 10, 2022

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.